EyePoint, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $522.00K, a 41.46% increase year-over-year.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $398.00K, a 97.03% increase year-over-year.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $767.00K, a 63.19% increase from fiscal 2024.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $470.00K, a 11.37% increase from fiscal 2023.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $422.00K, a 19.21% increase from fiscal 2022.
- EyePoint, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $354.00K, a 29.67% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $920.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $522.00K 10-Q · filed 2026-05-07 | $920.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $767.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $398.00K 10-Q · filed 2025-11-06 | $767.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $571.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $369.00K 10-Q · filed 2026-05-07 | $571.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $470.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $202.00K 10-Q · filed 2025-11-06 | $470.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $442.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $268.00K 10-Q · filed 2025-05-08 | $442.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $422.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $174.00K 10-Q · filed 2024-11-07 | $422.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $401.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $248.00K 10-Q · filed 2024-05-09 | $401.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $354.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $153.00K 10-Q · filed 2023-11-03 | $354.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $302.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $201.00K 10-Q · filed 2023-05-04 | $302.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $273.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $101.00K 10-Q · filed 2022-11-04 | $274.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $280.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $173.00K 10-Q · filed 2022-05-06 | $280.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $294.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $107.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | |
| 2020-03-31 | $187.00K 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |